Home › Funds › SECURITY BENEFIT LIFE INSURANCE CO /KS/ › SLXNW

SECURITY BENEFIT LIFE INSURANCE CO /KS/ position in SLXNW

SILEXION THERAPEUTICS CORP · Health Care

SECURITY BENEFIT LIFE INSURANCE CO /KS/ reported holding 150,000 shares of SLXNW (SILEXION THERAPEUTICS CORP) in its Q3 2026 13F filing — a position valued at US$1K, representing 0.00% of its reported portfolio and ranking #20 among its reported holdings. SECURITY BENEFIT LIFE INSURANCE CO /KS/ has disclosed SLXNW holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)150.00K sh
Reported value held$1.41K
Portfolio Weight0.00%
First reportedQ3 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SECURITY BENEFIT LIFE INSURANCE CO /KS/'s SLXNW position evolved

SECURITY BENEFIT LIFE INSURANCE CO /KS/ first disclosed a stake in SLXNW in Q3 2024 at 150,000 shares (US$5K). The position peaked in Q1 2025 at 150,000 shares, worth US$11K. Across 9 filings, SECURITY BENEFIT LIFE INSURANCE CO /KS/ held the position steady without any share-count change. The most recent filing (Q3 2026) shows 150,000 shares valued at US$1K.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 150.00K $4.72K New
Q4 2024 150.00K $5.04K Hold
Q1 2025 150.00K $10.52K Hold
Q2 2025 150.00K $5.71K Hold
Q3 2025 150.00K $5.28K Hold
Q4 2025 150.00K $4.08K Hold
Q1 2026 150.00K $1.88K Hold
Q2 2026 150.00K $4.56K Hold
Q3 2026 150.00K $1.41K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SLXNW and 13F data

SLXNW (SILEXION THERAPEUTICS CORP) is a Health Care company. 20 other funds we track also report a position in SLXNW — the largest reported positions include DUPONT CAPITAL MANAGEMENT CORP (US$306K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SLXNW

All SLXNW fund holders →

FAQ

How long has SECURITY BENEFIT LIFE INSURANCE CO /KS/ held SLXNW?

SECURITY BENEFIT LIFE INSURANCE CO /KS/ has disclosed SLXNW holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is SECURITY BENEFIT LIFE INSURANCE CO /KS/'s current position in SLXNW?

As of Q3 2026, SECURITY BENEFIT LIFE INSURANCE CO /KS/ holds 150.00K shares of SLXNW (SILEXION THERAPEUTICS CORP), valued at $1.41K, representing 0.00% of its reported portfolio and ranking #20.

Has SECURITY BENEFIT LIFE INSURANCE CO /KS/ been buying or selling SLXNW?

In the latest 13F filing (Q3 2026), SECURITY BENEFIT LIFE INSURANCE CO /KS/ held unchanged its position in SLXNW. The position peaked in Q1 2025 at 150.00K shares.

Which other funds hold SLXNW?

Other major institutional holders of SLXNW include DUPONT CAPITAL MANAGEMENT CORP, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.